{"cluster": 66, "subcluster": 0, "abstract_summ": "Since vaccines have high failure rates, as an alternative, we are presenting a new, designed multi-peptide subunit-based epitope vaccine against COVID-19.We have not only compared the peptide vaccine with other types of vaccines but also presented comprehensive literature information about development steps for an effective and protective formulation to give an insight into on-going peptide vaccine studies against SARS-CoV-2.Among all types of vaccines, epitope-based peptide vaccines outshine with their low-cost production, easy modification in the structure, and safety.In this review, vaccine studies against COVID-19 have been summarized and detailed information about the epitope-based peptide vaccines against COVID-19 has been provided.The immune-simulation by C-ImmSim server, which mimics the natural immune environment, yielded more potent immune response data of B-cells, Th cells, Tc cells and IgG for vaccine.", "title_summ": "Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenHigh throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19", "title_abstract_phrases": "Since vaccines have high failure rates, as an alternative, we are presenting a new, designed multi-peptide subunit-based epitope vaccine against COVID-19.Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenThe vaccine elicitation of broadly neutralizing antibodies against HIV-1 is a long-sought goal.We have not only compared the peptide vaccine with other types of vaccines but also presented comprehensive literature information about development steps for an effective and protective formulation to give an insight into on-going peptide vaccine studies against SARS-CoV-2.Among all types of vaccines, epitope-based peptide vaccines outshine with their low-cost production, easy modification in the structure, and safety.In this review, vaccine studies against COVID-19 have been summarized and detailed information about the epitope-based peptide vaccines against COVID-19 has been provided."}